Buy & Sell Novartis AG (NVS) – Novartis AG Price Today
Aura AI Summary
Key Stats
- $288.90BMarket Cap
- HealthSector
- -7.83%3M Drawdown
- $328.92BEnterprise Value
- 3.13%Dividend Yield
- 90% Buy | 10% SellTrading Activity
- 81 daysTypical Hold Time
Novartis AG (NVS) is currently valued at a market capitalization of $288.90B, with an enterprise value of $328.92B. Over the past 52 weeks, Novartis AG has traded between a low of $113.5 and a high of $168.62, highlighting its annual price range. Over the past three months, Novartis AG has recorded a drawdown of -7.83%, reflecting recent price volatility. Novartis AG offers a dividend yield of 3.13%, with the most recent dividend of $4.77 paid on 11 Mar 26. On average, investors hold Novartis AG for approximately 81 days, indicating typical investor behavior on the platform.
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Most Recent News
Air Comm opens new Dallas-Fort Worth office to boost local communication and security support in North Texas
Air Comm, a leading provider of wireless communication and security technology, has opened a new office in Farmers Branch, Texas, expanding its presence in the Dallas-Fort Worth area. This new location enhances Air Comm's ability to offer faster loca...

Metallium completes successful multi-unit Flash Joule Heating operations, boosting tech scalability confidence.
Metallium Limited has successfully operated three Flash Joule Heating units simultaneously at its Texas facility, marking a key milestone in scaling its proprietary technology. The operation achieved 83% availability and nearly 100% utilization, exce...

iRhythm probes cyberattack after hackers claim sensitive data breach and demand ransom
iRhythm Holdings disclosed a cybersecurity breach involving unauthorized access to data on third-party business applications. Hackers claimed to have sensitive company and patient information and demanded payment to avoid public release. The company ...
